Author

Maja Szramowska

Institution: Quorn (United Kingdom)

Observed institution: Quorn (United Kingdom)

ORCID: 0009-0001-5986-9718

Observed ORCID: 0009-0001-5986-9718

OpenAlex ID: A5059809992

Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs

2018 · Alan-Shaun Wilkinson, Michael Charles Allwood, et al. · PLoS ONE · 22

Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study

2024 · Benoit Bestgen, Sam Jones, et al. · The Lancet Infectious Diseases · 5

Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin

2024 · Andrea Kuemmerle, Denis Gossen, et al. · Clinical and Translational Science · 4

A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants

2024 · Andrea Kuemmerle, Denis Gossen, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 3

Works count: 4

Citation count: 34

H-index: 3

I10-index: 1